Andrea Klein Selected Research

Andrea Klein Research Topics

Disease

5	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2020 - 09/2015
4	Muscular Diseases (Myopathy) 01/2022 - 09/2011
3	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2022 - 02/2015
2	Neoplasms (Cancer) 10/2018 - 11/2011
2	Disease Progression 08/2017 - 10/2015
2	Scoliosis 01/2017 - 01/2014
2	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 10/2015 - 02/2013
1	Myasthenia Gravis 09/2022
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2022
1	Frontotemporal Dementia (Semantic Dementia) 01/2022
1	Body Weight (Weight, Body) 11/2021
1	Neuromuscular Diseases (Neuromuscular Disease) 11/2021
1	Necrosis 10/2019
1	Myotoxicity 10/2018
1	Infections 10/2018
1	Glioblastoma (Glioblastoma Multiforme) 10/2018
1	Hypophosphatemia 10/2018
1	Rhabdomyolysis 10/2018
1	Myoglobinuria 10/2018
1	Cardiomyopathies (Cardiomyopathy) 01/2017
1	Retinal Degeneration 01/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017
1	Neuromyelitis Optica (Devic's Disease) 08/2016
1	Cognitive Dysfunction 03/2015
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 03/2015
1	Hypertrophy 02/2015
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 12/2014
1	Seroma 04/2012
1	Surgical Wound 04/2012
1	Wounds and Injuries (Trauma) 04/2012
1	Ophthalmoplegia (External Ophthalmoplegia) 09/2011
1	Hypersensitivity (Allergy) 12/2010
1	Glycogen Storage Disease Type II (Pompe's Disease) 12/2010
1	Polymicrogyria 11/2008
1	Cysts 11/2008
1	Muscular Dystrophies (Muscular Dystrophy) 11/2008
1	Neural Tube Defects (Exencephaly) 01/2003
1	Meningocele 01/2003

Drug/Important Bio-Agent (IBA)

3	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 12/2014 - 09/2011
2	Proteins (Proteins, Gene)FDA Link 11/2021 - 10/2018
2	CitrullineIBA 12/2019 - 10/2019
2	Metformin (Glucophage)FDA LinkGeneric 12/2019 - 10/2019
1	Rituximab (Mabthera)FDA Link 09/2022
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022
1	nusinersenIBA 01/2022
1	RisdiplamIBA 11/2021
1	idebenoneIBA 01/2020
1	Amino Acids FDA Link 10/2019
1	Arginine (L-Arginine)FDA Link 10/2019
1	BiguanidesIBA 10/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 10/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2019
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	Zoledronic Acid (Zometa)FDA Link 10/2018
1	Anesthetics (Anesthetic Agents)IBA 10/2018
1	Diphosphonates (Bisphosphonates)IBA 10/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2018
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 10/2018
1	Transcription Factors (Transcription Factor)IBA 10/2018
1	myocardinIBA 10/2018
1	Oligoclonal BandsIBA 08/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017
1	Aconitate Hydratase (Aconitase)IBA 01/2017
1	AntibodiesIBA 08/2016
1	Myelin-Oligodendrocyte GlycoproteinIBA 08/2016
1	muskIBA 10/2015
1	dolichol monophosphate (dolichyl phosphate)IBA 03/2015
1	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 03/2015
1	Cytoplasmic DyneinsIBA 02/2015
1	Albuterol (Salbutamol)FDA LinkGeneric 02/2013
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 11/2011
1	Immunoglobulin E (IgE)IBA 12/2010
1	Omalizumab (Xolair)FDA Link 12/2010
1	human GAA protein (Myozyme)FDA Link 12/2010
1	GlycogenIBA 12/2010
1	GlucosidasesIBA 12/2010
1	anti-IgE antibodiesIBA 12/2010
1	EnzymesIBA 12/2010
1	AcidsIBA 12/2010
1	Dystroglycans (Dystroglycan)IBA 11/2008
1	protein O-mannose beta-1,2-N-acetylglucosaminyltransferaseIBA 11/2008
1	6- cyano- 5- methoxy- 12- methylindolo(2,3- a)carbazoleIBA 01/2003

Therapy/Procedure

1	Aftercare (After-Treatment) 10/2018
1	Therapeutics 09/2015
1	Denervation 02/2015
1	Enteral Nutrition (Feeding, Tube) 01/2014
1	Negative-Pressure Wound Therapy 04/2012
1	Hip Replacement Arthroplasty (Total Hip Replacement) 04/2012